RCUS

Stock ticker: NYSE

PRICE

CHANGE

CAPITALIZATION

Arcus Biosciences (RCUS) Earnings Date & Reports

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

RCUS is expected to report earnings to fall 2.63% to -111 cents per share on July 31

Arcus Biosciences RCUS Stock Earnings Reports

Q2'25

Est.

$-1.11

Q1'25

Missed

by $0.12

Q4'24

Beat

by $0.20

Q3'24

Beat

by $0.02

Q2'24

Beat

by $0.09

The last earnings report on May 06 showed earnings per share of -113 cents, missing the estimate of -101 cents. With 245.22K shares outstanding, the current market capitalization sits at 931.79M.

View a ticker or compare two or three

Compare

Search For Dips Search For Dips

Annualized Return+30%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

RCUS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For RCUS
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for RCUS (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a company which offers pre-clinical drug discovery and development solutions

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

3928 Point Eden Way

Phone

+1 510 694-6200

Employees

577

Web

https://www.arcusbio.com